Quote For Amylin Pharmaceuticals, Inc. AMLN.O
Amylin Pharmaceuticals, Inc. (AMLN.O) (Nasdaq)
sector: Healthcare ·
industry: Biotechnology ·
$13.91
25 Nov 2009
+5.06%
$13.91
--
3,427,078
$14.06
$13.25
$15.69
$5.92
1.66
1,686,285
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Costa, Paulo | Chairman of the Board | -- |
| Bradbury, Daniel | President, Chief Executive Officer, Director | 4,059,276 |
| Foletta, Mark | Chief Financial Officer, Senior Vice President - Finance | 1,252,962 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $1,971.64 |
| Shares Outstanding (Mil.) | 141.74 |
| Float (Mil.) | 138.00 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 2.93 |
| Current Ratio | 3.15 |
| LT Debt/Equity | 159.19 |
| Total Debt/Equity | 165.94 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 2.41 |
| Price/Book(TTM) | 4.26 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-1.73 |
| Sales(TTM) | $5.85 |
| Book Value(MRQ) | $3.26 |
| Cash Flow(TTM) | $-1.49 |
| Cash(MRQ) | $4.37 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -52.93 |
| Return on Assets(TTM) | -14.57 |
| Return on Investment(TTM) | -17.53 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 89.34 |
| Operating Margin(TTM) % | -27.71 |
| Profit Margin(TTM) % | -29.39 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
